John Papadopoulos
Papers
2
Total Citations
10
H-Index
2
About
John Papadopoulos is a urologic oncologist whose research focuses on optimizing surgical and neoadjuvant treatment strategies for penile and prostate cancers. His most cited work examines the comparative effectiveness of robotic versus open superficial inguinal lymph node dissection for clinically node-negative high-risk penile cancer, a study that has garnered 7 citations and addresses a critical gap in minimally invasive staging techniques. Papadopoulos also leads a Phase II trial investigating 6 months of apalutamide prior to radical prostatectomy in intermediate-risk prostate cancer patients, aiming to reduce pathologic features that necessitate post-operative radiation therapy—a study with 3 citations that explores novel neoadjuvant paradigms. His contributions are particularly impactful in refining surgical approaches to reduce morbidity while maintaining oncologic control, and in advancing perioperative systemic therapy for prostate cancer. With a growing citation footprint, Papadopoulos’s work is shaping clinical decision-making for high-stakes genitourinary malignancies, offering evidence that bridges surgical innovation and targeted pharmacotherapy. His research is essential reading for urologists and oncologists seeking to improve outcomes through personalized, stage-appropriate interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2